| 000 | 01062 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514170039.0 | ||
| 264 | 0 | _c20040227 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a0041-1337 | ||
| 024 | 7 |
_a10.1097/01.TP.0000101038.20305.C9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJorga, Anamarija | |
| 245 | 0 | 0 |
_aPatient management by cyclosporine C2 monitoring. _h[electronic resource] |
| 260 |
_bTransplantation _cJan 2004 |
||
| 300 |
_a323-4 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aComplement C2 _xanalysis |
| 650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
| 650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
| 650 | 0 | 4 | _aMonitoring, Physiologic |
| 700 | 1 | _aJohnston, Atholl | |
| 700 | 1 | _aHolt, David W | |
| 773 | 0 |
_tTransplantation _gvol. 77 _gno. 2 _gp. 323-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.TP.0000101038.20305.C9 _zAvailable from publisher's website |
| 999 |
_c14467852 _d14467852 |
||